Monashee Investment Management »

Regulus Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $352k 197k 1.79
2024-03-31 $1.8M 625k 2.88

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Aercap Holdings Nv SHS (AER)
Birkenstock Holding Com Shs (BIRK)
Ares Management Corporation Cl A Com Stk (ARES)
Dell Technologies CL C (DELL)
Corebridge Finl (CRBG)
Advanced Micro Devices (AMD)
Kenvue (KVUE)

View all positions for Monashee Investment Management

Top funds holding Regulus Therapeutics

Federated Investors
RA Capital Management
Vivo Capital
Octagon Capital Advisors
Vanguard Group
BlackRock
Adage Capital Partners GP
Deep Track Capital
FMR
Opaleye Management
Geode Capital Management
Millennium Management
State Street Corporation
Woodline Partners
Alyeska Investment Group

View all funds holding Regulus Therapeutics